How'd you fix Casper's revenue issues in 2026?

Question

Pulse RevOps · The Machine · Accepted Answer

**Direct Answer:** Casper's revenue problem is structural: a low-margin mattress commodity with long replacement cycles, decimated customer acquisition costs (DTC darling to private-equity salvage), and failed retail expansion (wholesale margin compression from Costco/Target). The 2026 fix is omnichannel rationalization + subscription bed-health services + vertical integration into adjacent sleep tech (Eight Sleep POD), not more mattress SKUs.

**What's Broken**

**The IPO Collapse Story**
Casper IPO'd Feb 2020 at $12/share, hit $14.50 on day one—$575M valuation, down from $1.1B private. By Nov 2021, stock crashed ~75%, Durational Capital took it private at $6.90/share ($286M—75% haircut). Why: public markets punished:
- Losing ~$300/mattress at scale (DTC CAC >$400, ACV ~$1,200, long payback)
- Profitability mirage: 50% gross margin buried under marketing spend ($67M loss on $312M revenue in 9m 2019)
- Long replacement cycle (8–10 years): no SaaS-like recurring revenue; perpetual churn grind

**DTC Mattress Market Over-Saturation (2018–2025)**
- 2019: 175+ DTC mattress brands (Tuft&Needle, Purple, Saatva, Helix, Nectar, Avocado, Boll&Branch, Leesa, Amerisleep)
- All played the same playbook: Facebook/Google paid CAC, "bed-in-a-box" hype, Target/Costco distribution deals
- Result: consolidation, price wars, wholesale margin collapse
- By 2025: U.S. mattress market only $9.13B, growing 3.37% CAGR to 2033 (not 20%+ growth Casper needed pre-IPO)

**Retail Expansion Betrayal**
- Target partnership (2016): $75M investment, shelf space in 1,200+ stores
- Costco/wholesale deals: stripped gross margin from 50% to ~35% (mattress commoditized)
- Casper retail stores (40+ by 2025): fixed overhead, unproductive real estate
- Result: omnichannel complexity without omnichannel profitability—DTC margin killed by wholesale undercutting

**Brand Drift to "Sleep Wellness" (Failed Diversification)**
- Pillows, bedding, dog beds, "sleep wellness" category expansion
- None solved the real problem: mattress is a 10-year buy, not a repeat purchase
- Adjacent products (pillows, sheets) are low-margin, high-clutter (Brooklinen, Parachute, Threshold@Target already owned this)

**2026 Revenue Fix Playbook (5 Moves)**

**Move 1: Rationalize Omnichannel (Cut Leakage)**

Stop pretending Casper is a mass-market mattress brand. Collapse the channel conflict:

- **Sunset wholesale:** Kill Costco/Target SKUs (margin poison). Use Resident (Mattress Firm's omnichannel retail platform) or build a B2B2C model where retailers sell Casper under white-label backend, Casper keeps margin.
- **Consolidate retail:** Close underperforming Casper Sleep Shops; keep 8–12 flagship experience centers in Top 50 metros only (NYC, SF, LA, Austin, Denver, Chicago).
- **DTC as primary:** Web + phone + 8 flagships as touchpoints. Margin back to 45–50% (no wholesale tax).

**Impact:** Recover ~$15–20M in annual gross margin (10% of current revenue) by killing margin-dilutive wholesale.

**Move 2: Lock In Subscription Bed Health (Recurring Revenue Moat)**

Matches are commodities; **sleep health subscriptions** are not. Launch Casper+ (inspired by Eight Sleep's POD software + Apple Fitness+ pricing model):

- **Casper+ Smart Sleep Plan:** $15/month subscription. Customers get:
  - Sleep score tracking (integrate with Apple Watch, Oura Ring, phones)
  - Dynamic mattress stiffness recommendations (if buying Casper POD hybrid)
  - Sleep coaching AI (personalized wind-down routines, temperature, humidity)
  - Exclusive discounts on pillows, sheets, cooling toppers
  - Expert Q&A (sleep doc rotation)

- **Unit economics:**
  - Mattress ARPU: $1,200 (one-time, 10-year cycle)
  - Casper+ subscription: $180/year per customer
  - Attach rate target: 40% of new customers (low barrier to entry)
  - 5-year LTV per customer: $1,200 + (0.40 × $900) = $1,560
  - CAC (DTC): $350
  - LTV:CAC ratio: 4.4x (excellent for DTC)

- **Why Eight Sleep as a template:**
  Eight Sleep (now $1.5B private valuation, 2025) cracked this: sell a premium "smart mattress" (POD, $3,500), then drive recurring revenue through subscription software ($70/mo). Their Pod generates $500M+ lifetime revenue; the subscription is the profit engine.

**Move 3: Launch Casper POD Competitor (High-Margin Sleep Tech)**

Don't license Eight Sleep; **build Casper Sleep Intelligence POD:** dual-zone temperature control + sleep-stage biofeedback (heart rate, movement) + AI micro-adjustments.

- **Price:** $2,800 (vs Eight Sleep's $3,500)
- **Target:** High-income couples ($100k+) who already have Casper, willing to upgrade
- **Margin:** 55% (manufactured in Vietnam, sold DTC)
- **Attach to subscription:** 80% of POD buyers subscribe to Casper+ (mandatory first-month free trial)
- **Year 1 revenue opportunity:** 2,000 POD sales × $2,800 × 55% margin = $3.08M gross profit
- **Year 3 revenue opportunity:** 15,000 POD sales × $2,800 × 55% + (50,000 active subscriptions × $180) = $31.2M gross profit

**Why:** Eight Sleep's 1

Segment	Annual Ad Spend	Customers Acquired	CAC	ARPU (Mat + Year 1 Sub)	LTV:CAC
Wellness Athletes	$1.5M	6,250	$240	$1,380	5.75x
Couples (POD upsell)	$800k	2,500	$320	$2,800	8.75x
Medical Clinics	$400k	1,500	$267	$1,380	5.16x
Total	$2.7M	10,250	$263	$1,470	5.6x

How'd you fix Casper's revenue issues in 2026?

What does the score mean?